Home
Account
Research Tools
Educate
Contribute
News
Sectors
Premium
About Us
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Chart School
Tutorials
Learning Center
Glossary
Submit Article
Join Blog Network
Rate Broker
Rate Software
Earnings
Dividend
Management Changes
M&A
Analyst
FDA
IPO
About Us
Contact Us
Advertise With Us
Editorial Staff
Terms and Conditions
Privacy Policy
iStock Rating
D
Details...
Enter Symbol
Repligen Corporation (NASDAQ: RGEN)
Sector: Medical
Current Price :
$8.85
52 Week Low
$3.80
52 Week High
$9.10
Company
Overview
Research Notes
Company Profile
Competitors
Community
Stock Sentiment
Whisper Estimates
Enter Estimates
Message Board
Analysis
Blog Articles
Press Releases
Charts
Technical Charts
Analyst
Analyst Ratings
Analyst Estimates
Sales Estimates
Ratios
Financial Ratios
Technicals
Shares Outstanding:
31M
Market Cap:
$0.28B
Avg Volume:
402273
P/E Ratio:
18.850
PEG Ratio:
-0.010
1m
3m
6m
1y
2y
Opinion and Analysis
Moving Towards A Top?
Sep 10, 2012 08:44 PM |
AAPL
,
ACTG
,
AMZN
,
GMCR
,
GOOG
,
GS
Repligen (RGEN) Drops After FDA Setback Over Pancreatic Imaging Agent Review
Apr 26, 2012 12:38 PM |
RGEN
Regeneron Pharma (RGEN): New Lipid Lowering Therapies Offer Long-Term Growth
Mar 15, 2012 08:59 PM |
RGEN
More Articles on RGEN..
Press Releases
Repligen Reports First Quarter 2013 Financial Results
May 02, 2013 07:31 AM |
RGEN
Repligen to Report First Quarter 2013 Financial Results
Apr 23, 2013 05:36 PM |
RGEN
Free Research Reports on BYD, NLY, RGEN and VLO Issued by the Bedford Report
Apr 08, 2013 08:15 AM |
BYD
,
NLY
,
RGEN
,
VLO
More Press Releases on RGEN..
SEC Filings
Form 4 REPLIGEN CORP For: Feb 28 Filed by: WITT DANIEL P (10K)
Mar 12, 2013 10:33 AM
Form 4 REPLIGEN CORP For: Feb 28 Filed by: RUSCHE JAMES R (10K)
Mar 12, 2013 10:20 AM
Form 4 REPLIGEN CORP For: Feb 28 Filed by: Kelly William J (10K)
Mar 12, 2013 10:12 AM
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
RGEN
Compare to S&P
YTD
41.08 %
29.38 %
4 Weeks
37.15 %
37.30 %
12 Weeks
24.79 %
20.59 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
342.86 %
EPS Growth in Last Year:
542.86 %
Sales Growth in Last Quarter:
24.56 %
Sales Growth in Last Quarter:
162.58 %
More...
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
Quotemedia
. Advertisement partners
Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##